Toshihiko Matsuo Selected Research

2- (2- (4- (dibutylamino)phenyl)ethenyl)- 3- carboxymethylbenzothiazolium

12/2021	Effect of NK-5962 on Gene Expression Profiling of Retina in a Rat Model of Retinitis Pigmentosa.
6/2021	Photoelectric Dye, NK-5962, as a Potential Drug for Preventing Retinal Neurons from Apoptosis: Pharmacokinetic Studies Based on Review of the Evidence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshihiko Matsuo Research Topics

Disease

10	Retinitis Pigmentosa (Pigmentary Retinopathy) 12/2021 - 07/2007
8	Strabismus (Squint) 02/2024 - 08/2003
8	Cataract (Cataracts) 06/2023 - 04/2004
7	Lymphoma (Lymphomas) 01/2023 - 11/2009
5	Retinal Detachment (Retinal Detachments) 03/2024 - 02/2005
5	Lymphadenopathy 01/2023 - 01/2012
5	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2021 - 11/2007
4	COVID-19 01/2024 - 01/2022
4	Intraocular Lymphoma 01/2022 - 11/2009
4	Melanoma (Melanoma, Malignant) 01/2022 - 04/2014
3	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 03/2024 - 10/2007
3	Optic Neuritis (Retrobulbar Neuritis) 01/2024 - 12/2002
3	Scleritis (Episcleritis) 06/2023 - 04/2002
3	Infections 02/2023 - 02/2006
3	Neoplasm Metastasis (Metastasis) 01/2023 - 01/2019
3	Paralysis (Palsy) 08/2022 - 04/2005
3	Uveitis 01/2022 - 02/2006
3	Hemorrhage 01/2022 - 03/2002
3	Esotropia (Esophoria) 12/2021 - 06/2003
3	Exotropia (Exophoria) 12/2021 - 06/2003
3	Macular Degeneration (Age-Related Maculopathy) 12/2021 - 08/2018
3	Retinal Dystrophies 06/2021 - 06/2017
3	Neoplasms (Cancer) 01/2021 - 06/2004
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2018 - 11/2009
3	Inflammation (Inflammations) 12/2014 - 02/2006
2	Abscess 12/2023 - 02/2023
2	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 06/2023 - 03/2007
2	Hypesthesia (Numbness) 02/2023 - 12/2002
2	Multiple Sclerosis 01/2023 - 12/2002
2	Adenocarcinoma 01/2023 - 01/2021
2	Pathologic Complete Response 01/2023 - 12/2022
2	Fever (Fevers) 01/2022 - 12/2021
2	Atrophy 12/2021 - 01/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2021 - 06/2006
2	Immunoglobulin G4-Related Disease 01/2021 - 01/2011
2	Iridocyclitis 01/2020 - 11/2002
2	Macular Edema 01/2020 - 01/2002
2	Edema (Dropsy) 01/2017 - 03/2002
2	Acute Retinal Necrosis Syndrome 01/2012 - 02/2005
2	Hemangioma (Angioma) 04/2011 - 03/2009
2	Orbital Pseudotumor 01/2010 - 09/2004
2	Retinal Vein Occlusion 11/2008 - 03/2007
2	White Dot Syndromes 03/2007 - 04/2002
2	Vasculitis (Vasculitides) 03/2007 - 11/2002
2	Dry Eye Syndromes (Dry Eye Syndrome) 07/2004 - 11/2002
2	Glaucoma 06/2004 - 09/2003
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 06/2004 - 09/2003
1	Abducens Nerve Diseases (Sixth Nerve Palsy) 01/2024
1	Periodontitis 01/2024
1	Pericardial Effusion 01/2024

Drug/Important Bio-Agent (IBA)

10	Retinaldehyde (Retinal)IBA 01/2020 - 01/2002
8	Prednisolone (Predate)FDA LinkGeneric 03/2024 - 02/2005
8	Coloring Agents (Dyes)IBA 12/2023 - 01/2009
6	Rituximab (Mabthera)FDA Link 06/2023 - 01/2012
5	NucleotidesIBA 08/2022 - 09/2003
4	SteroidsIBA 03/2024 - 12/2010
4	mRNA VaccinesIBA 01/2024 - 01/2022
4	DNA (Deoxyribonucleic Acid)IBA 12/2021 - 06/2003
4	Immunoglobulins (Immunoglobulin)IBA 01/2017 - 11/2007
4	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 01/2012 - 09/2004
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 02/2011
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 06/2023 - 04/2002
3	Methotrexate (Mexate)FDA LinkGeneric 01/2023 - 01/2020
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022 - 01/2014
3	Ophthalmic Solutions (Eye Drops)IBA 01/2022 - 11/2002
3	Immunoglobulin G (IgG)IBA 01/2021 - 02/2006
3	Fluorescein (Funduscein)FDA LinkGeneric 03/2009 - 01/2002
2	Peroxidase (Myeloperoxidase)IBA 06/2023 - 03/2007
2	Bendamustine Hydrochloride FDA Link 01/2023 - 01/2014
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2023 - 12/2022
2	Vincristine (Oncovin)FDA LinkGeneric 12/2022 - 01/2017
2	AntibodiesIBA 01/2022 - 01/2019
2	Monophenol Monooxygenase (Tyrosinase)IBA 01/2022 - 01/2019
2	ParaffinIBA 01/2022 - 09/2004
2	Adalimumab (Humira)FDA Link 12/2021 - 01/2020
2	2- (2- (4- (dibutylamino)phenyl)ethenyl)- 3- carboxymethylbenzothiazoliumIBA 12/2021 - 06/2021
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 10/2007
2	Deoxyglucose (2 Deoxy D glucose)IBA 01/2017 - 04/2014
2	Interferon-alpha (Interferon Alfa)IBA 11/2008 - 12/2002
2	Proteins (Proteins, Gene)FDA Link 02/2008 - 12/2002
2	SolutionsIBA 07/2004 - 11/2002
2	TrehaloseIBA 07/2004 - 11/2002
2	Amino Acids FDA Link 06/2004 - 09/2003
2	EnzymesIBA 04/2004 - 08/2003
2	NitrogenIBA 09/2003 - 08/2003
1	leukotriene-C4 synthaseIBA 02/2024

Therapy/Procedure

12	Vitrectomy 12/2022 - 02/2005
9	Therapeutics 03/2024 - 03/2009
7	Drug Therapy (Chemotherapy) 12/2022 - 03/2002
5	Visual Prosthesis 01/2021 - 07/2007
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2023 - 01/2015
3	Radiotherapy 01/2021 - 01/2011
3	Hematopoietic Stem Cell Transplantation 01/2017 - 01/2012
2	Intraocular Lenses (Intraocular Lens) 01/2022 - 01/2014
2	Renal Dialysis (Hemodialysis) 01/2021 - 06/2006
2	Prostheses and Implants (Prosthesis) 01/2021 - 04/2012
2	Intraocular Lens Implantation 01/2020 - 01/2014
2	Combination Drug Therapy (Combination Chemotherapy) 01/2014 - 01/2012
2	Lasers (Laser) 06/2004 - 06/2002
1	Stents 01/2024